These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
690 related articles for article (PubMed ID: 19699865)
1. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors. De Luca G; Gibson CM; Huber K; Zeymer U; Dudek D; Cutlip D; Bellandi F; Noc M; Emre A; Zorman S; Gabriel HM; Maioli M; Rakowski T; Gyöngyösi M; Van't Hof AW; Am Heart J; 2009 Sep; 158(3):416-21. PubMed ID: 19699865 [TBL] [Abstract][Full Text] [Related]
2. Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure. De Luca G; van 't Hof AW; de Boer MJ; Hoorntje JC; Gosselink AT; Dambrink JH; Ottervanger JP; Zijlstra F; Suryapranata H Circulation; 2004 Mar; 109(8):958-61. PubMed ID: 14981008 [TBL] [Abstract][Full Text] [Related]
3. Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. De Luca G; van 't Hof AW; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; Zijlstra F; de Boer MJ; Suryapranata H Am Heart J; 2005 Sep; 150(3):557-62. PubMed ID: 16169340 [TBL] [Abstract][Full Text] [Related]
4. Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors. Maioli M; Zeymer U; van 't Hof AW; Gibson CM; Dudek D; Bellandi F; Noc M; Secco GG; Zorman S; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Huber K; De Luca G; J Invasive Cardiol; 2012 Jul; 24(7):324-7. PubMed ID: 22781470 [TBL] [Abstract][Full Text] [Related]
5. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors. De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F; J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096 [TBL] [Abstract][Full Text] [Related]
6. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW; Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677 [TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. De Luca G; Gibson CM; Bellandi F; Noc M; Dudek D; Zeymer U; Arntz HR; Cutlip D; Maioli M; Zorman S; Mesquita Gabriel H; Emre A; Rakowski T; Gyongyosi M; Huber K; Van't Hof AW Atherosclerosis; 2009 Nov; 207(1):181-5. PubMed ID: 19426981 [TBL] [Abstract][Full Text] [Related]
8. Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. De Luca G; Gibson CM; Huber K; Dudek D; Cutlip D; Zeymer U; Gyöngyösi M; Bellandi F; Noc M; Arntz HR; Maioli M; Secco GG; Zorman S; Gabriel HM; Emre A; Rakowski T; Van't Hof AW; EuroIntervention; 2012 Aug; 8(4):470-6. PubMed ID: 22917731 [TBL] [Abstract][Full Text] [Related]
9. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty]. Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338 [TBL] [Abstract][Full Text] [Related]
10. Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplasty. De Luca G; Ernst N; van 't Hof AW; Ottervanger JP; Hoorntje JC; Dambrink JH; Gosslink AT; de Boer MJ; Suryapranata H Am Heart J; 2005 Oct; 150(4):827-31. PubMed ID: 16209989 [TBL] [Abstract][Full Text] [Related]
11. Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study. De Luca G; Suryapranata H; Dambrink JH; Ottervanger JP; van 't Hof AW; Zijlstra F; Hoorntje JC; Gosselink AT; de Boer MJ Am Heart J; 2004 Nov; 148(5):852-6. PubMed ID: 15523317 [TBL] [Abstract][Full Text] [Related]
12. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry. Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155 [TBL] [Abstract][Full Text] [Related]
13. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. De Luca G; Ernst N; van 't Hof AW; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; de Boer MJ; Suryapranata H Am Heart J; 2006 Jun; 151(6):1256-9. PubMed ID: 16781232 [TBL] [Abstract][Full Text] [Related]
14. X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. Lefèvre T; Garcia E; Reimers B; Lang I; di Mario C; Colombo A; Neumann FJ; Chavarri MV; Brunel P; Grube E; Thomas M; Glatt B; Ludwig J; J Am Coll Cardiol; 2005 Jul; 46(2):246-52. PubMed ID: 16022950 [TBL] [Abstract][Full Text] [Related]
15. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty. Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP; Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144 [TBL] [Abstract][Full Text] [Related]
16. Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. De Luca G; Suryapranata H; van 't Hof AW; Ottervanger JP; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ Am Heart J; 2006 Jun; 151(6):1296.e1-6. PubMed ID: 16781239 [TBL] [Abstract][Full Text] [Related]
17. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. De Luca G; van't Hof AW; Huber K; Gibson CM; Bellandi F; Arntz HR; Maioli M; Noc M; Zorman S; Secco GG; Zeymer U; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Dudek D Heart Vessels; 2014 Jan; 29(1):15-20. PubMed ID: 23494604 [TBL] [Abstract][Full Text] [Related]
18. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538 [TBL] [Abstract][Full Text] [Related]
19. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME; J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683 [TBL] [Abstract][Full Text] [Related]
20. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]